HuGE Literature Finder
Records
1
-
16
| Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA). Orphanet journal of rare diseases 2021 Jul 16 (1): 301. Sauter Matthias, Belousova Elena, Benedik Mirjana P, Carter Tom, Cottin Vincent, Curatolo Paolo, Dahlin Maria, D'Amato Lisa, d'Augères Guillaume B, de Vries Petrus J, Ferreira José C, Feucht Martha, Fladrowski Carla, Hertzberg Christoph, Jozwiak Sergiusz, Lawson John A, Macaya Alfons, Marques Ruben, Nabbout Rima, O'Callaghan Finbar, Qin Jiong, Sander Valentin, Shah Seema, Takahashi Yukitoshi, Touraine Renaud, Youroukos Sotiris, Zonnenberg Bernard, Jansen Anna, Kingswood J Chris, |
| TP53 Variant Allele Frequency Correlates with the Chemotherapy Response Score in Ovarian/Fallopian Tube/Peritoneal High-Grade Serous Carcinoma. Human pathology 2021 Jun . Lawson Barrett C, Yang Richard K, Euscher Elizabeth D, Ramalingam Preetha, Malpica Ana |
| Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma. Translational andrology and urology 2020 Dec 9 (6): 2751-2763. Bi Hai, Yin Jipeng, Zhou Lang, Wu Yaqian, Ge Liyuan, Lu Min, Liu Lei, Zhang Hongxian, Zhao Yongzhe, Liu Cheng, Ma Lul |
| Differences in Genomic Alterations Between Brain Metastases and Primary Tumors. Neurosurgery 2020 Dec . Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar |
| Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study. Current cancer drug targets 2020 11 . Gilyazova Irina R, Beeraka Narasimha M, Klimentova Elizaveta A, Bulygin Kirill V, Nikolenko Vladimir N, Izmailov Adel A, Gilyazova Gulshat R, Pavlov Valentin N, Khusnutdinova Elsa K, Somasundaram Siva G, Kirkland Cecil E, Aliev Gjumrak |
| Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular cancer therapeutics 2019 Oct . Nassar Amin H, Hamieh Lana, Gray Kathryn P, Thorner Aaron R, Fay Andre P, Lasseter Kathryn D, Abou Alaiwi Sarah, Nuzzo Pier Vitale, Flippot Ronan, Krajewski Katherine M, Signoretti Sabina, Choueiri Toni K, Kwiatkowski David |
| Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence. Journal of hepatology 2019 Jul . Zhou Shao-Lai, Zhou Zheng-Jun, Hu Zhi-Qiang, Song Cheng-Li, Luo Yi-Jie, Luo Chu-Bin, Xin Hao-Yang, Yang Xin-Rong, Shi Ying-Hong, Wang Zheng, Huang Xiao-Wu, Cao Ya, Fan Jia, Zhou Ji |
| Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma. British journal of cancer 2018 Sep 119 (6): 707-712. Bellmunt Joaquim, Lalani Aly-Khan A, Jacobus Sussana, Wankowicz Stephanie A, Polacek Laura, Takeda David Y, Harshman Lauren C, Wagle Nikhil, Moreno Irene, Lundgren Kevin, Bossé Dominick, Van Allen Eliezer M, Choueiri Toni K, Rosenberg Jonathan |
| Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing. Gynecologic oncology 2018 02 148 (2): 375-382. Kim Se Ik, Lee Ji Won, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sang, Seo Jeong-S |
| Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma. European urology focus 2017 Aug . Isharwal Sumit, Audenet François, Drill Esther, Pietzak Eugene J, Iyer Gopa, Ostrovnaya Irina, Cha Eugene, Donahue Timothy, Arcila Maria, Jayakumaran Gowtham, Berger Michael F, Rosenberg Jonathan E, Bajorin Dean F, Coleman Jonathan, Dalbagni Guido, Reuter Victor E, Bochner Bernard H, Solit David B, Al-Ahmadie Hikmat |
| Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2017 Jun . Shu Xiang, Purdue Mark P, Ye Yuanqing, Tu Huakang, Wood Christopher G, Tannir Nizar M, Wang Zhaoming, Albanes Demetrius, Gapstur Susan M, Stevens Victoria L, Rothman Nathaniel, Chanock Stephen J, Wu Xife |
| Do patients with tuberous sclerosis complex have an increased risk for malignancies? American journal of medical genetics. Part A 2016 Apr . Peron Angela, Vignoli Aglaia, La Briola Francesca, Volpi Angela, Montanari Emanuele, Morenghi Emanuela, Ghelma Filippo, Bulfamante Gaetano, Cefalo Graziella, Canevini Maria Pao |
| Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Feb . Kwiatkowski David J, Choueiri Toni K, Fay Andre P, Rini Brian I, Thorner Aaron R, De Velasco Guillermo, Tyburczy Magdalena, Hamieh Lana, Albiges Laurence, Agarwal Neeraj, Ho Thai H, Song Jiaxi, Pignon Jean-Christophe, Barrios Pablo M, Michaelson M Dror, Van Allen Eliezer M, Krajewski Katherine M, Porta Camillo, Pal Sumanta Kumar, Bellmunt Joaquim, McDermott David F, Heng Daniel Y C, Gray Kathryn P, Signoretti Sabi |
| Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget 2015 Dec . Goh Gerald, Walradt Trent, Markarov Vladimir, Blom Astrid, Riaz Nadeem, Doumani Ryan, Stafstrom Krista, Moshiri Ata, Yelistratova Lola, Levinsohn Jonathan, Chan Timothy A, Nghiem Paul, Lifton Richard P, Choi Jaehy |
| Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Feb 27 (2): 271-80. Ross Jeffrey S, Wang Kai, Al-Rohil Rami N, Nazeer Tipu, Sheehan Christine E, Otto Geoff A, He Jie, Palmer Gary, Yelensky Roman, Lipson Doron, Ali Siraj, Balasubramanian Sohail, Curran John A, Garcia Lazlo, Mahoney Kristen, Downing Sean R, Hawryluk Matthew, Miller Vincent A, Stephens Philip |
| A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1. PloS one 2011 6 (4): e18583. Sjödahl Gottfrid, Lauss Martin, Gudjonsson Sigurdur, Liedberg Fredrik, Halldén Christer, Chebil Gunilla, Månsson Wiking, Höglund Mattias, Lindgren Dav |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: